Search
Kiniksa Pharmaceuticals International PLC
KNSAAdd to Watchlist
79.150USD
+15.615+24.58%
Close 07-28 16:00（ET）Quotes delayed by 15 min
6.04BMarket Cap
81.35P/E TTM
KNSA Financials
See Kiniksa Pharmaceuticals International PLC's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Kiniksa Pharmaceuticals International PLC Earnings Date
Latest Release
Jul 28, 2026
EPS / Forecast
0.33/0.30
Revenue / Forecast
243.60M/225.46M
Period
FY2025 Earnings
Revenue(YoY)
677.56M
60.09%
EPS(YoY)
0.80
231.50%
Analyst Rating
BUY
2026/07/28
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its total revenue reached 677.56M, with a year-on-year change of 423.24M.
What are the current assets of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its current assets were 527.18M, with a year-on-year change of 58.88.
What are the total assets of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its total assets of Kiniksa Pharmaceuticals International PLC were 763.63M, with a year-on-year change of 31.54.
What are the total liabilities of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its total liabilities of Kiniksa Pharmaceuticals International PLC were 196.03M, with a year-on-year change of 37.93.
What is the total equity of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its total equity of Kiniksa Pharmaceuticals International PLC was 567.61M, with a year-on-year change of 29.46.
What is the net operating income of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its net operating income of Kiniksa Pharmaceuticals International PLC was 77.22M, with a year-on-year change of 269.28.
What is the net investment of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its net investment of Kiniksa Pharmaceuticals International PLC was -188.99M, with a year-on-year change of -601.68.
What is the net financing of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its net financing of Kiniksa Pharmaceuticals International PLC was 33.02M, with a year-on-year change of 169.22.
What is the Earnings Per Share (EPS) of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its Earnings Per Share (EPS) was 0.80, with a year-on-year change of 231.50.
What is the net income of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its net income was 59.01M, with a year-on-year change of 236.61.
What is the net margin of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its net profit margin was 8.71, with a year-on-year change of 185.33.
What is the gross margin of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its gross margin was 88.54, with a year-on-year change of 3.42.
What is the Return on Equity (ROE) of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its Return on Equity (ROE) was 11.73, with a year-on-year change of 219.12.
What is the Return on Assets (ROA) of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its Return on Assets (ROA) was 8.78, with a year-on-year change of 212.49.
What is the operating profit of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2025 earnings report, its operating profit was 77.22M, with a year-on-year change of 269.28.